Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 20- Open
- $34.02
- 52-wk high
- $40.71
- High
- $34.39
- 52-wk low
- $27.55
- Low
- $33.50
- Prev close
- $34.20
Smart money
Earnings
Earnings came in $0.01 a share below what analysts expected.
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $103.7M | $77.4M | $106.7M | $115.9M |
| Cost of what it sold | $513.0K | $2.6M | $434.0K | $1.1M |
| Gross profit | $103.2M | $74.8M | $106.2M | $114.8M |
| What it spent | ||||
| Research and development | $70.6M | $58.4M | $61.1M | $73.9M |
| Sales and admin | $39.8M | $42.6M | $37.9M | $43.9M |
| Other operating costs | — | -$11.7M | — | — |
| Total operating expenses | $110.4M | $89.4M | $99.0M | $117.8M |
| What was left | ||||
| Operating profit | -$7.2M | -$14.6M | $7.3M | -$3.0M |
| Interest on debt | $3.0M | $3.1M | $2.3M | $3.1M |
| Profit before tax | $304.0K | -$11.7M | $13.3M | -$514.0K |
| Tax | -$481.0K | $10.6M | $300.5K | $294.0K |
| Net profit | $785.0K | -$22.3M | $13.0M | -$808.0K |
| EBITDA | $4.1M | -$8.0M | $16.5M | $3.6M |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
80 / 100
RSI 14
20D volatility
52-week range
20D support
News
What the news says
Coverage is bullish
Tone of tracked coverage
How Investors May Respond To Immunocore (IMCR) Turning First-Half Profit Amid Recent Share Price Pullback
Leans bullishAug 14How Investors May Respond To Immunocore (IMCR) Turning First-Half Profit Amid Recent Share Price Pullback
BullishAug 14How Investors May Respond To Immunocore (IMCR) Turning First-Half Profit Amid Recent Share Price Pullback
Bullish